Fast Enrolling Influenza Vaccine Study
Rho recently conducted a flu vaccine study, and our team enrolled 360+ patients in 3 days at 4 clinical sites. The study had 96.9% retention through day 50 of the study and 90.4% of participants completed their final visit on day 345 of the study.
Our study team built and maintains excellent relationships with the clinical sites that participated in this study.
I have so enjoyed working with Rho. I’ve been in this business for 14 years, and I have to say that Rho is the best CRO I have ever worked with.
Associate Director, Clinical Operations, sponsor company